A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
Last week, the U.S. Food and Drug Administration (FDA) added a new therapeutic to the armamentarium for oncologists treating...
Earlier this week, the U.S. Food and Drug Association (FDA) announced it had approved the immunotherapeutic atezolizumab (Tecentriq) for...
Cancer Today Senior Editor Marci A. Landsmann shares her experience reporting on a young lung cancer survivor, Emily Bennett...
Liver cancer rates have been on the rise in the United States and have tripled in the last four...
Understanding the identity of the factors that increase risk for a particular type of cancer is vital for developing...
The potential for developing new immunotherapies and expanding the use of existing ones will be the focus of the...
In examination rooms all around the country, a big decision turns on a single moment. A pediatrician tells a...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today Slightly more than 57 million people were 60...
Stand Up To Cancer’s highly successful 2016 fundraising telecast will help keep up the pace of progress against cancer,...
For four straight years, the American Association for Cancer Research has been the founding organizer and lead supporter for...